Progevera 10 mg® Versus Orgalutran® in Ovarian Stimulation Cycles of Oocyte Donors
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years to 35 Years (Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Oocyte donors included in the oocyte donation program of Clinica EUGIN.
1st oocyte donation cycle at Clínica EUGIN.
Polycistic Ovarian syndrome (PCOs).
Estradiol levels on day 2 of menstrual cycle >70 pg/ml.
Hormone treatments up to 3 months before the oocyte donation cycle.
Medical contraindication to the treatments used in the study